{
    "organizations": [],
    "uuid": "36062cfcc4da4cd58530fcde322d8304276d79a9",
    "author": "",
    "url": "https://www.reuters.com/article/brief-amarin-corporation-says-ministry-o/brief-amarin-corporation-says-ministry-of-public-health-in-lebanon-approved-vascepa-idUSFWN1R308S",
    "ord_in_thread": 0,
    "title": "BRIEF-Amarin Corporation Says ‍Ministry Of Public Health In Lebanon Approved Vascepa",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 21, 2018 / 9:05 AM / Updated 8 minutes ago BRIEF-Amarin Corporation Says ‍Ministry Of Public Health In Lebanon Approved Vascepa Reuters Staff March 21 (Reuters) - Amarin Corporation Plc: * AMARIN ANNOUNCES FIRST MIDDLE EAST APPROVAL FOR VASCEPA® * AMARIN CORPORATION PLC - ‍MINISTRY OF PUBLIC HEALTH IN LEBANON HAS APPROVED VASCEPA​ * AMARIN - ‍REV POTENTIAL FOR VASCEPA OUTSIDE U.S. SEEN TO BE RELATIVELY MODEST UNTIL ADDITIONAL COUNTRIES​ APPROVAL * AMARIN CORPORATION PLC - ‍APPROVED AS PRESCRIPTION MEDICATION AS ADJUNCT TO DIET TO REDUCE TG LEVELS IN ADULT PATIENTS WITH SEVERE HYPERTRIGLYCERIDEMIA​ Source text for Eikon: Further company coverage:",
    "published": "2018-03-21T11:03:00.000+02:00",
    "crawled": "2018-03-21T11:18:11.002+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "updated",
        "minute",
        "ago",
        "corporation",
        "say",
        "public",
        "health",
        "lebanon",
        "approved",
        "vascepa",
        "reuters",
        "staff",
        "march",
        "reuters",
        "amarin",
        "corporation",
        "plc",
        "amarin",
        "announces",
        "first",
        "middle",
        "east",
        "approval",
        "amarin",
        "corporation",
        "plc",
        "public",
        "health",
        "lebanon",
        "approved",
        "amarin",
        "potential",
        "vascepa",
        "outside",
        "seen",
        "relatively",
        "modest",
        "additional",
        "approval",
        "amarin",
        "corporation",
        "plc",
        "prescription",
        "medication",
        "adjunct",
        "diet",
        "reduce",
        "tg",
        "level",
        "adult",
        "patient",
        "severe",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}